Drug Topics March 14, 2025
Brian Nowosielski, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed the common trends in GLP-1 use she’s seen amongst her patients as well as her extensive experience working with this medication class.

Glucagon-like peptide-1 (GLP-1) receptor agonists have been on the prescription drug market for around 20 years. However, with recent indications for obesity and other comorbidities in this medication class, GLP-1s have seen a significant rise in the past few years.

“When anything new comes out, at first, there are some people that really jump on board and want to try it and then others who have some hesitancy,” said Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, Endocrine Clinical Pharmacy Specialist with Cleveland Clinic Endocrinology & Metabolism Institute. “You hear sometimes...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech
Deep learning uncovers gene targets and potential drugs to slow brain aging
CZI’s Priscilla Chan on ‘Virtual Cells’ AI Models to Cure Diseases
Ensitrelvir Shows Promise Preventing COVID-19 Post Exposure
Gene Therapy Biotech MeiraGTx Strikes Deal Bringing Generative AI to Pivotal Parkinson’s Trial
Pharma Pulse 3/14/25: Navigating Internal Constraints and Uncertainty, Health Plan Support During Natural Disasters & more

Share This Article